Menu

• Ask a Health Expert about HAEMOLYTIC URAEMIC SYNDROME
• Post Your Side Effect related to HAEMOLYTIC URAEMIC SYNDROME
• HAEMOLYTIC URAEMIC SYNDROME and FDA Warnings
• HAEMOLYTIC URAEMIC SYNDROME in Patients Wiki
• Report HAEMOLYTIC URAEMIC SYNDROME in Drug Side Effect Survey

HAEMOLYTIC URAEMIC SYNDROME side effect

What is HAEMOLYTIC URAEMIC SYNDROME ?

A Health Expert wants to answer your question. Please provide details below.

Type your question here

 letters left

Melphalan Side Effects Report #5661265-1
Consumer or non-health professional from JAPAN reported MELPHALAN problem on Feb 28, 2008. Female patient, child 6 years of age, was diagnosed with prophylaxis against graft versus host disease and was treated with MELPHALAN. After drug was administered, patient experienced the following problems/side effects: haemolytic uraemic syndrome, . MELPHALAN dosage: 70MGM2 PER DAY. During the same period patient was treated with TOTAL BODY IRRADIATION, THIOTEPA, CYCLOPHOSPHAMIDE, CYCLOSPORINE, STEM CELL TRANSPLANT. Patient recovered.

Capecitabine Side Effects Report #5663200-9
CAPECITABINE problem was reported by a Physician from AUSTRALIA on Mar 04, 2008. Male patient, 64 years of age, was treated with CAPECITABINE. After drug was administered, patient experienced the following problems/side effects: haemolytic uraemic syndrome, . CAPECITABINE dosage: unknown. During the same period patient was treated with BEVACIZUMAB, MITOMYCIN. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5672544-6
Consumer or non-health professional from UNITED KINGDOM reported BEVACIZUMAB problem on Mar 04, 2008. Male patient was diagnosed with colorectal cancer metastatic and was treated with BEVACIZUMAB. After drug was administered, patient experienced the following problems/side effects: haemolytic uraemic syndrome, nephritis interstitial, thrombocytopenia, . BEVACIZUMAB dosage: 560 MG, Q3W. During the same period patient was treated with CAPECITABINE, MITOMYCIN. Patient was hospitalized. Patient recovered.

Melphalan Side Effects Report #5677166-9
MELPHALAN problem was reported by a Physician from JAPAN on Mar 17, 2008. Female patient, child 6 years of age, was diagnosed with acute lymphocytic leukaemia, prophylaxis against graft versus host disease and was treated with MELPHALAN. After drug was administered, patient experienced the following problems/side effects: haemolytic uraemic syndrome, . MELPHALAN dosage: 70MGM2 PER DAY. During the same period patient was treated with TOTAL BODY IRRADIATION, THIOTEPA, CYCLOPHOSPHAMIDE, CYCLOSPORINE, STEM CELL TRANSPLANT. Patient recovered.


Tacrolimus Side Effects Report #5688368-X
Pharmacist from UNITED STATES reported TACROLIMUS problem on Mar 28, 2008. Male patient, 54 years of age, weighting 207.2 lb, was diagnosed with transplant and was treated with TACROLIMUS. After drug was administered, patient experienced the following problems/side effects: haemolytic uraemic syndrome, post procedural complication, thrombotic thrombocytopenic purpura, . TACROLIMUS dosage: 5MG Q12H PO. Patient was hospitalized. Patient recovered.

Betaferon Side Effects Report #5611820-X
BETAFERON problem was reported by a Health Professional from GERMANY on Jan 23, 2008. Female patient, 38 years of age, was diagnosed with relapsing-remitting multiple sclerosis and was treated with BETAFERON. After drug was administered, patient experienced the following problems/side effects: haemolytic uraemic syndrome, pleural effusion, renal failure, . BETAFERON dosage: unknown. During the same period patient was treated with HORMONES AND RELATED AGENTS. Patient was hospitalized. Patient recovered.

Gemzar Side Effects Report #5626318-2
Physician from UNITED STATES reported GEMZAR problem on Feb 04, 2008. Female patient, 59 years of age, was diagnosed with breast cancer stage iv and was treated with GEMZAR. After drug was administered, patient experienced the following problems/side effects: haemolytic uraemic syndrome, malignant neoplasm progression, renal failure, thrombotic thrombocytopenic purpura, . GEMZAR dosage: 1250 MG/M2, UNK. During the same period patient was treated with TAXOL. Patient died.

Infliximab Side Effects Report #5639015-4
INFLIXIMAB problem was reported by a Physician from UNITED KINGDOM on Feb 15, 2008. Female patient, weighting 145.5 lb, was diagnosed with crohn's disease, renal failure acute, thrombocytopenia and was treated with INFLIXIMAB. After drug was administered, patient experienced the following problems/side effects: haemolytic uraemic syndrome, malaise, thrombocytopenia, urticaria, . INFLIXIMAB dosage: unknown. During the same period patient was treated with MERCAPTOPURINE. Patient was hospitalized and became disabled. Patient recovered.

Infliximab Side Effects Report #5643603-9
Physician from UNITED KINGDOM reported INFLIXIMAB problem on Feb 19, 2008. Female patient, weighting 138.9 lb, was diagnosed with crohn's disease, renal failure acute, thrombocytopenia and was treated with INFLIXIMAB. After drug was administered, patient experienced the following problems/side effects: haemolytic uraemic syndrome, infusion related reaction, malaise, renal failure acute, thrombocytopenia, urticaria, . INFLIXIMAB dosage: unknown. During the same period patient was treated with MERCAPTOPURINE. Patient was hospitalized and became disabled. Patient recovered.


Gemzar Side Effects Report #5581814-1
GEMZAR problem was reported by a Physician from UNITED STATES on Dec 24, 2007. Female patient, 59 years of age, was diagnosed with breast cancer stage iv and was treated with GEMZAR. After drug was administered, patient experienced the following problems/side effects: haemolytic uraemic syndrome, hypertension, renal failure, thrombotic thrombocytopenic purpura, . GEMZAR dosage: 1250 MG/M2, UNK. During the same period patient was treated with TAXOL. Patient recovered.

Ibuprofen Side Effects Report #5592395-0
Physician from NETHERLANDS reported IBUPROFEN problem on Dec 28, 2007. Female patient, 44 years of age, was diagnosed with dysmenorrhoea and was treated with IBUPROFEN. After drug was administered, patient experienced the following problems/side effects: haemolytic uraemic syndrome, . IBUPROFEN dosage: unknown. Patient was hospitalized. Patient recovered.

Acyclovir Side Effects Report #5597081-9
ACYCLOVIR problem was reported by a Physician from UNITED STATES on Jan 10, 2008. Male patient, 34 years of age, weighting 176.8 lb, was treated with ACYCLOVIR. After drug was administered, patient experienced the following problems/side effects: haemolytic uraemic syndrome, haemophilus sepsis, pain, pyrexia, thrombocytopenia, . ACYCLOVIR dosage: unknown. During the same period patient was treated with BIAXIN, DECADRON, POTASSIUM CHLORIDE, LOTREL, MEPRON, VITAMIN CAP, PREDNISONE, SIROLIMUS. Patient was hospitalized. Patient recovered.

Prednisone Side Effects Report #5599347-5
Consumer or non-health professional from SWEDEN reported PREDNISONE problem on Jan 07, 2008. Male patient, child 9 years of age, was diagnosed with graft versus host disease and was treated with PREDNISONE. After drug was administered, patient experienced the following problems/side effects: haemolytic uraemic syndrome, toxic epidermal necrolysis, . PREDNISONE dosage: unknown. During the same period patient was treated with METHYLPREDNISOLONE ACETATE, CYCLOSPORINE, NIFEDIPINE, DEXCHLORPHENIRAMINE, SULFAMETHOXAZOLE, MEROPENEM, MORPHINE, FUROSEMIDE. Patient was hospitalized. Patient recovered.

Rituxan Side Effects Report #5610227-9
RITUXAN problem was reported by a Physician from FRANCE on Jan 25, 2008. Female patient, 56 years of age, was diagnosed with b-cell lymphoma and was treated with RITUXAN. After drug was administered, patient experienced the following problems/side effects: haemolytic uraemic syndrome, . RITUXAN dosage: 375 MG/M2, Q2W. During the same period patient was treated with GEMCITABINE, OXALIPLATIN, LEVOTHYROXINE, HYDROCORTISONE. Patient died.


Cyclosporine Side Effects Report #5559076-0
Consumer or non-health professional from SWEDEN reported CYCLOSPORINE problem on Dec 04, 2007. Male patient, child 9. years of age, was diagnosed with graft versus host disease and was treated with CYCLOSPORINE. After drug was administered, patient experienced the following problems/side effects: haemolytic uraemic syndrome, toxic epidermal necrolysis, . CYCLOSPORINE dosage: unknown. During the same period patient was treated with ACETAMINOPHEN, ACYCLOVIR, AMPICILLIN, MORPHINE, VANCOMYCIN, PREDNISOLONE. Patient was hospitalized. Patient recovered.

Alprostadil Side Effects Report #5575904-7
ALPROSTADIL problem was reported by a Consumer or non-health professional from JAPAN on Dec 05, 2007. Female patient, 28 years of age, was treated with ALPROSTADIL. After drug was administered, patient experienced the following problems/side effects: haemolytic uraemic syndrome, thrombotic thrombocytopenic purpura, . ALPROSTADIL dosage: unknown. During the same period patient was treated with GABEXATE MESILATE, TACROLIMUS, MYCOPHENOLATE MOFETIL, MARVELON. Patient recovered.

Gemzar Side Effects Report #5505421-1
Physician from UNITED STATES reported GEMZAR problem on Oct 26, 2007. Female patient was diagnosed with breast cancer and was treated with GEMZAR. After drug was administered, patient experienced the following problems/side effects: haemolytic uraemic syndrome, thrombotic thrombocytopenic purpura, . GEMZAR dosage: unknown. During the same period patient was treated with TAXOL. Patient recovered.

Gemcitabine Side Effects Report #5518942-2
GEMCITABINE problem was reported by a Pharmacist from UNITED STATES on Nov 13, 2007. Female patient, 48 years of age, weighting 149.9 lb, was diagnosed with bile duct cancer and was treated with GEMCITABINE. After drug was administered, patient experienced the following problems/side effects: haemolytic uraemic syndrome, thrombotic thrombocytopenic purpura, . GEMCITABINE dosage: 1672MG QWEEK X 3 WEEKS IV. During the same period patient was treated with IBUPROFEN, BELLAMINE, OXYCODONE, ZOFRAN, SENNA, PROTONIX, COMPAZINE, HYDROCHLOROTHIAZIDE. Patient was hospitalized and became disabled. Patient recovered.

Rebif Side Effects Report #5521574-3
Consumer or non-health professional from GERMANY reported REBIF problem on Nov 02, 2007. Female patient, 28 years of age, weighting 112.4 lb, was diagnosed with multiple sclerosis and was treated with REBIF. After drug was administered, patient experienced the following problems/side effects: haemolytic uraemic syndrome, pleural effusion, rash, renal failure acute, renal tubular necrosis, . REBIF dosage: unknown. Patient was hospitalized. Patient recovered.


Betaseron Side Effects Report #5522666-5
BETASERON problem was reported by a Consumer or non-health professional from UNITED STATES on Nov 08, 2007. Female patient, 42 years of age, was diagnosed with relapsing-remitting multiple sclerosis, rosacea and was treated with BETASERON. After drug was administered, patient experienced the following problems/side effects: haemolytic uraemic syndrome, injection site pain, . BETASERON dosage: unknown. During the same period patient was treated with MINOCYCLINE. Patient was hospitalized. Patient recovered.

Methylprednisolo Side Effects Report #5524346-9
Consumer or non-health professional from SWEDEN reported METHYLPREDNISOLONE problem on Nov 12, 2007. Male patient, child 9 years of age, was diagnosed with graft versus host disease and was treated with METHYLPREDNISOLONE. After drug was administered, patient experienced the following problems/side effects: haemolytic uraemic syndrome, toxic epidermal necrolysis, . METHYLPREDNISOLONE dosage: unknown. During the same period patient was treated with PREDNISONE, PREDNISOLONE, CYCLOSPORINE, SULFAMETHOXAZOLE AND TRIMETHOPRIM, ALLOPURINOL, METHOTREXATE, ACYCLOVIR, FLUCONAZOLE. Patient recovered.

Gemzar Side Effects Report #5478561-3
GEMZAR problem was reported by a Physician from JAPAN on Sept 25, 2007. Female patient, weighting 100.5 lb, was diagnosed with prophylaxis of nausea and vomiting and was treated with GEMZAR. After drug was administered, patient experienced the following problems/side effects: haemolytic uraemic syndrome, pericardial effusion, . GEMZAR dosage: 1400 MG, UNK. During the same period patient was treated with ELPLAT, KYTRIL. Patient was hospitalized. Patient recovered.

Ibuprofen Side Effects Report #5485109-6
Health Professional from NETHERLANDS reported IBUPROFEN problem on Oct 09, 2007. Female patient, 44 years of age, was diagnosed with dysmenorrhoea and was treated with IBUPROFEN. After drug was administered, patient experienced the following problems/side effects: haemolytic uraemic syndrome, . IBUPROFEN dosage: unknown. Patient was hospitalized. Patient recovered.

Betaseron Side Effects Report #5487087-2
BETASERON problem was reported by a Consumer or non-health professional from GERMANY on Oct 02, 2007. Female patient, 38 years of age, was diagnosed with relapsing-remitting multiple sclerosis and was treated with BETASERON. After drug was administered, patient experienced the following problems/side effects: haemolytic uraemic syndrome, renal failure, . BETASERON dosage: unknown. During the same period patient was treated with HORMONES AND RELATED AGENTS. Patient was hospitalized. Patient recovered.

Rapamune Side Effects Report #5492199-3
Physician from UNITED STATES reported RAPAMUNE problem on Feb 26, 2007. Female patient was diagnosed with prophylaxis against transplant rejection and was treated with RAPAMUNE. After drug was administered, patient experienced the following problems/side effects: haemolytic uraemic syndrome, . RAPAMUNE dosage: unknown. During the same period patient was treated with CELLCEPT. Patient recovered.

Sevoflurane Side Effects Report #5493836-X
SEVOFLURANE problem was reported by a Health Professional from JAPAN on Oct 15, 2007. Male patient, weighting 145.5 lb, was diagnosed with induction of anaesthesia and was treated with SEVOFLURANE. After drug was administered, patient experienced the following problems/side effects: haemolytic uraemic syndrome, multi-organ failure, . SEVOFLURANE dosage: unknown. During the same period patient was treated with NITROUS OXIDE, ETILEFRINE HYDROCHLORIDE, CEFTAZIDIME, THIAMYLAL, SUXAMETHONIUM CHLORIDE, PANCURONIUM BROMIDE, LIDOCAINE. Patient was hospitalized. Patient recovered.

Ibuprofene Side Effects Report #5495053-6
Health Professional from NETHERLANDS reported IBUPROFENE RPG problem on Oct 10, 2007. Female patient was treated with IBUPROFENE RPG. After drug was administered, patient experienced the following problems/side effects: haemolytic uraemic syndrome, . IBUPROFENE RPG dosage: 400 MG, UNK. Patient was hospitalized. Patient recovered.

Gemzar Side Effects Report #5499355-9
GEMZAR problem was reported by a Physician from JAPAN on Oct 16, 2007. Female patient, weighting 100.5 lb, was diagnosed with prophylaxis of nausea and vomiting and was treated with GEMZAR. After drug was administered, patient experienced the following problems/side effects: haemolytic uraemic syndrome, pericardial effusion, . GEMZAR dosage: 1400 MG, UNK. During the same period patient was treated with ELPLAT, KYTRIL. Patient was hospitalized. Patient recovered.

Ibuprofene Side Effects Report #5503077-5
Health Professional from NETHERLANDS reported IBUPROFENE RPG problem on Oct 17, 2007. Female patient was diagnosed with dysmenorrhoea and was treated with IBUPROFENE RPG. After drug was administered, patient experienced the following problems/side effects: haemolytic uraemic syndrome, . IBUPROFENE RPG dosage: 400 MG, UNK. Patient was hospitalized. Patient recovered.

Infliximab Side Effects Report #5466804-1
INFLIXIMAB problem was reported by a Physician from UNITED KINGDOM on Sept 18, 2007. Female patient, weighting 143.3 lb, was diagnosed with crohn's disease and was treated with INFLIXIMAB. After drug was administered, patient experienced the following problems/side effects: haemolytic uraemic syndrome, . INFLIXIMAB dosage: unknown. During the same period patient was treated with MERCAPTOPURINE. Patient was hospitalized. Patient recovered.

Rifampicin Side Effects Report #5406898-2
Consumer or non-health professional from IRELAND reported RIFAMPICIN problem on July 18, 2007. Male patient, child 3 years of age, was diagnosed with meningitis meningococcal and was treated with RIFAMPICIN. After drug was administered, patient experienced the following problems/side effects: haemolytic uraemic syndrome, haemorrhage, hypovolaemic shock, . RIFAMPICIN dosage: unknown. Patient died on 11/14/2004.

Gemzar Side Effects Report #5407411-6
GEMZAR problem was reported by a Physician from UNITED STATES on Aug 01, 2007. Female patient, 45 years of age, was diagnosed with breast cancer and was treated with GEMZAR. After drug was administered, patient experienced the following problems/side effects: haemolytic uraemic syndrome, pleural effusion, pulmonary oedema, renal failure chronic, . GEMZAR dosage: 800 MG/M2, OTHER. Patient was hospitalized. Patient recovered.

Feiba Side Effects Report #5411309-7
Consumer or non-health professional from JAPAN reported FEIBA VH IMMUNO problem on Aug 02, 2007. Male patient, 52 years of age, weighting 127.9 lb, was diagnosed with gastrointestinal haemorrhage and was treated with FEIBA VH IMMUNO. After drug was administered, patient experienced the following problems/side effects: haemolytic uraemic syndrome, thrombosis, . FEIBA VH IMMUNO dosage: unknown. During the same period patient was treated with NOVOSEVEN. Patient was hospitalized. Patient recovered.

Mycophenolate Side Effects Report #5412666-8
MYCOPHENOLATE MOFETIL problem was reported by a Health Professional from AUSTRALIA on Aug 02, 2007. Male patient, 50 years of age, weighting 200.6 lb, was treated with MYCOPHENOLATE MOFETIL. After drug was administered, patient experienced the following problems/side effects: haemolytic uraemic syndrome, . MYCOPHENOLATE MOFETIL dosage: unknown. During the same period patient was treated with EVEROLIMUS, CYCLOSPORINE, BACTRIM, VALGANCICLOVIR, AMPHOTERICIN B, PREDNISOLONE. Patient recovered.

Arava Side Effects Report #5436053-1
Pharmacist from UNITED KINGDOM reported ARAVA problem on Aug 22, 2007. Female patient was treated with ARAVA. After drug was administered, patient experienced the following problems/side effects: haemolytic uraemic syndrome, renal failure acute, thrombotic thrombocytopenic purpura, . ARAVA dosage: unknown. During the same period patient was treated with DOXAZOSIN MESYLATE, OMEPRAZOLE, FOLIC ACID, TRIMAZOLE, DICLOFENAC. Patient was hospitalized. Patient recovered.

Sprycel Side Effects Report #5390381-7
SPRYCEL problem was reported by a Physician from FRANCE on July 16, 2007. Female patient, 58 years of age, weighting 145.5 lb, was diagnosed with chronic myeloid leukaemia, hypertension, cardiac failure, tremor, depression and was treated with SPRYCEL. After drug was administered, patient experienced the following problems/side effects: haemolytic uraemic syndrome, . SPRYCEL dosage: unknown. During the same period patient was treated with PERINDOPRIL ERBUMINE, DIGOXIN, MYSOLINE, PROZAC. Patient was hospitalized. Patient recovered.

Sprycel Side Effects Report #5390381-7
Physician from FRANCE reported SPRYCEL problem on July 16, 2007. Female patient, 58 years of age, weighting 145.5 lb, was diagnosed with chronic myeloid leukaemia, hypertension, cardiac failure, tremor, depression and was treated with SPRYCEL. After drug was administered, patient experienced the following problems/side effects: haemolytic uraemic syndrome, . SPRYCEL dosage: unknown. During the same period patient was treated with PERINDOPRIL ERBUMINE, DIGOXIN, MYSOLINE, PROZAC. Patient was hospitalized. Patient recovered.

Mitomycin Side Effects Report #5755729-X
MITOMYCIN problem was reported by a Consumer or non-health professional from JAPAN on May 26, 2008. Female patient, 48 years of age, was diagnosed with breast cancer metastatic and was treated with MITOMYCIN. After drug was administered, patient experienced the following problems/side effects: haemolytic uraemic syndrome, pleural effusion, . MITOMYCIN dosage: unknown. During the same period patient was treated with FASLODEX. Patient was hospitalized. Patient recovered.

Plavix Side Effects Report #5767627-6
Physician from UNITED STATES reported PLAVIX problem on June 04, 2008. Male patient was treated with PLAVIX. After drug was administered, patient experienced the following problems/side effects: haemolytic uraemic syndrome, thrombocytopenic purpura, . PLAVIX dosage: unknown. Patient was hospitalized. Patient recovered.

Nuvaring Side Effects Report #5741424-X
NUVARING problem was reported by a Consumer or non-health professional from GERMANY on May 02, 2008. Female patient, 28 years of age, was diagnosed with contraception and was treated with NUVARING. After drug was administered, patient experienced the following problems/side effects: haemolytic uraemic syndrome, . NUVARING dosage: unknown. During the same period patient was treated with MIGRAEFLUX, GRIPPOSIAD C, ACETAMINOPHEN. Patient recovered.

Betaferon Side Effects Report #5749523-3
Health Professional from GERMANY reported BETAFERON problem on May 14, 2008. Female patient, 38 years of age, was diagnosed with relapsing-remitting multiple sclerosis and was treated with BETAFERON. After drug was administered, patient experienced the following problems/side effects: haemolytic uraemic syndrome, renal failure, . BETAFERON dosage: unknown. During the same period patient was treated with HORMONES AND RELATED AGENTS. Patient was hospitalized. Patient recovered.

Betaferon Side Effects Report #5751958-X
BETAFERON problem was reported by a Physician from GERMANY on May 14, 2008. Female patient, 38 years of age, weighting 132.3 lb, was diagnosed with relapsing-remitting multiple sclerosis and was treated with BETAFERON. After drug was administered, patient experienced the following problems/side effects: haemolytic uraemic syndrome, renal failure, . BETAFERON dosage: unknown. During the same period patient was treated with HORMONES. Patient was hospitalized. Patient recovered.

Gemzar Side Effects Report #5675384-7
Physician from UNITED STATES reported GEMZAR problem on Mar 28, 2007. Female patient, 51 years of age, was diagnosed with ovarian cancer and was treated with GEMZAR. After drug was administered, patient experienced the following problems/side effects: haemolytic uraemic syndrome, . GEMZAR dosage: 1900 MG, INTRAVENOUS;1900 MG, INTRAVENOUS; 1900 MG, INTRAVENOUS; 1900 MG, INTRAVENOUS. During the same period patient was treated with CARBOPLATIN. Patient was hospitalized. Patient recovered.

Gemzar Side Effects Report #5675393-8
GEMZAR problem was reported by a Physician from UNITED STATES on Feb 12, 2007. Female patient, 75 years of age, was diagnosed with pancreatic carcinoma and was treated with GEMZAR. After drug was administered, patient experienced the following problems/side effects: haemolytic uraemic syndrome, . GEMZAR dosage: 1000 MG/M2, OTHER, INTRAVENOUS. During the same period patient was treated with ANTIHYPERTENSIVES. Patient died on 02/01/2007.

Capecitabine Side Effects Report #5692304-X
Physician from AUSTRALIA reported CAPECITABINE problem on Mar 26, 2008. Male patient, 64 years of age, was treated with CAPECITABINE. After drug was administered, patient experienced the following problems/side effects: haemolytic uraemic syndrome, . CAPECITABINE dosage: unknown. During the same period patient was treated with BEVACIZUMAB, MITOMYCIN. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5696329-X
BEVACIZUMAB problem was reported by a Consumer or non-health professional from UNITED KINGDOM on Mar 26, 2008. Male patient was diagnosed with colorectal cancer metastatic and was treated with BEVACIZUMAB. After drug was administered, patient experienced the following problems/side effects: haemolytic uraemic syndrome, . BEVACIZUMAB dosage: 560 MG, Q3W. During the same period patient was treated with CAPECITABINE, MITOMYCIN. Patient was hospitalized. Patient recovered.

Tretinoin Side Effects Report #5721766-4
Health Professional from ITALY reported TRETINOIN problem on Apr 17, 2008. Female patient, 45 years of age, was treated with TRETINOIN. After drug was administered, patient experienced the following problems/side effects: haemolytic uraemic syndrome, . TRETINOIN dosage: unknown. During the same period patient was treated with IDARUBICIN, TRANEXAMIC ACID. Patient was hospitalized. Patient recovered.

Winrho Side Effects Report #5365791-4
WINRHO SDF problem was reported by a Pharmacist from UNITED STATES on May 31, 2007. Female patient, 72 years of age, weighting 253.5 lb, was diagnosed with idiopathic thrombocytopenic purpura and was treated with WINRHO SDF. After drug was administered, patient experienced the following problems/side effects: haemolytic uraemic syndrome, influenza like illness, renal failure acute, . WINRHO SDF dosage: unknown. During the same period patient was treated with SOTALOL HYDROCHLORIDE, DIOVAN, LIPITOR, GLUCOPHAGE, CARDIZEM, CELEBREX, CENTRUM. Patient was hospitalized. Patient recovered.

Mabthera Side Effects Report #5368040-6
Consumer or non-health professional from UNITED KINGDOM reported MABTHERA problem on June 15, 2007. Female patient, 44 years of age, was diagnosed with b-cell lymphoma and was treated with MABTHERA. After drug was administered, patient experienced the following problems/side effects: haemolytic uraemic syndrome, . MABTHERA dosage: unknown. During the same period patient was treated with OLANZAPINE, IMMUNE GLOBULIN INTRAVENOUS, ANTIBIOTICS. Patient was hospitalized. Patient recovered.

Winrho Side Effects Report #5330656-0
WINRHO problem was reported by a Pharmacist from UNITED STATES on May 18, 2007. Female patient, weighting 253.5 lb, was diagnosed with idiopathic thrombocytopenic purpura and was treated with WINRHO. After drug was administered, patient experienced the following problems/side effects: haemolytic uraemic syndrome, influenza like illness, infusion related reaction, . WINRHO dosage: unknown. Patient was hospitalized. Patient recovered.

Fluorouracil Side Effects Report #5286128-5
Consumer or non-health professional from GREECE reported FLUOROURACIL problem on Mar 23, 2007. Male patient, 52 years of age, was diagnosed with colon cancer and was treated with FLUOROURACIL. After drug was administered, patient experienced the following problems/side effects: haemolytic uraemic syndrome, . FLUOROURACIL dosage: DOSE: 400 MG/M2 BOLUS ON DAYS 1, 2 FOLLOWED BY 600 MG/M2 CONTINUOUS INFUSION FOR 22 HOURS. During the same period patient was treated with LEUCOVORIN CALCIUM. Patient recovered.